Results 21 to 30 of about 38,142 (215)

Senescence Is Associated With Elevated Intracellular Resting [Ca2 +] in Mice Skeletal Muscle Fibers. An in vivo Study

open access: yesFrontiers in Physiology, 2021
Aging causes skeletal muscles to become atrophied, weak, and easily fatigued. Here, we have tested the hypothesis that normal aging in skeletal muscle cells is associated with Ca2+ intracellular dyshomeostasis and oxidative stress.
Alfredo Mijares   +2 more
doaj   +1 more source

Malignant Hyperthermia in Sweden: Clinical Presentations and Genetic Findings. [PDF]

open access: yesActa Anaesthesiol Scand
ABSTRACT Introduction Malignant hyperthermia (MH) is a pharmacogenetic, hypermetabolic and potentially lethal reaction to potent volatile anaesthetics and the muscle relaxant succinylcholine. To improve the understanding of MH, the aim of this retrospective study was to describe the Swedish cohort with respect to clinical manifestations, demographics ...
Hellblom A, Soller M, Samuelsson C.
europepmc   +2 more sources

Intracellular calcium leak lowers glucose storage in human muscle, promoting hyperglycemia and diabetes

open access: yeseLife, 2020
Most glucose is processed in muscle, for energy or glycogen stores. Malignant Hyperthermia Susceptibility (MHS) exemplifies muscle conditions that increase [Ca2+]cytosol. 42% of MHS patients have hyperglycemia.
Eshwar R Tammineni   +7 more
doaj   +1 more source

Prevalence of malignant hyperthermia diagnosis in obstetric patients in the United States, 2003 to 2014

open access: yesBMC Anesthesiology, 2020
Background The cost-benefit of stocking dantrolene in maternity units for treating malignant hyperthermia (MH) has been recently questioned because of the low incidence of MH crisis in the general population and the low utilization of general anesthesia ...
Jean Guglielminotti   +2 more
doaj   +1 more source

Functional effects of mutations in the skeletal muscle ryanodine receptor type 1 (RYR1) linked to malignant hyperthermia and central core disease [PDF]

open access: yes, 2006
Malignant hyperthermia (MH) is a pharmacogenetic disorder with autosomal dominant inheritance. In susceptible individuals, a MH crisis may be triggered by commonly used halogenated anaesthetics (halothane, isoflurane) or muscle relaxants ...
Ducreux, Sylvie
core   +1 more source

Hyperthermia combined with chemotherapy - Biological rationale, clinical application, and treatment results [PDF]

open access: yes, 1999
There is substantial evidence from preclinical data that the antitumor cytotoxicity of selected chemotherapeutic agents either alone or combined with radiation can be enhanced by appropriate heat exposure (40-44 degrees C) of cells or tumor tissues ...
Issels, R.D., Issels, Rolf-Dieter
core   +1 more source

Skeletal muscle microalterations in patients carrying Malignant Hyperthermia-related mutations of the e-c coupling machinery

open access: yesEuropean Journal of Translational Myology, 2016
We have compared the ultrastructure of skeletal muscle biopsies from patients that have survived a [Malignant Hyperthermia, MH] episode and siblings that test positive for MH susceptibility with those from siblings that tested negatives.
Manuela Lavorato   +3 more
doaj   +1 more source

Calcium homeostasis and role of ryanodine receptor type 1 (RyR1) in immune cells [PDF]

open access: yes, 2010
Ryanodine receptors are intracellular Ca2+ release channels located in the membrane of the Endoplasmatic/Sarcoplasmatic Reticulum. Ryanodine receptor 1 isoform is preferentially expressed in skeletal muscle where it is responsible for release of Ca2 ...
Vukcevic, Mirko
core   +1 more source

Malignant hyperthermia: A case report

open access: yesHuman Pathology Reports, 2023
Malignant hyperthermia is a rare hypermetabolic pharmacogenetic pathologic disorder of calcium release control in skeletal muscle following exposure to depolarizing muscle relaxants and inhalational anesthetics in general anesthesia.
Fereshteh Amiri   +2 more
doaj   +1 more source

Variants in ASPH cause exertional heat illness and are associated with malignant hyperthermia susceptibility

open access: yesNature Communications, 2022
The genetic cause(s) of malignant hyperthermia and exertional heat illness are unknown in approximately 30% of cases. To address this barrier, the authors performed genome sequencing on a large cohort of cases, identifying rare variants in ASPH, a gene ...
Yukari Endo   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy